Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Xylazine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 437Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Alivira Animal Health
    India
    		 ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam IN R0-CEP 2021-030 - Rev 00 Xylazine hydrochloride for veterinary use, Process-II 2023-05-16 Valid Chemical 1481
    28/10/2024 Alivira Animal Health
    India
    		 ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam IN R0-CEP 2016-257 - Rev 03 Xylazine hydrochloride for veterinary use 2023-04-18 Withdrawn by Holder Chemical 2023-05-17 1481